Literature DB >> 2526700

Allogenic induction of thromboplastin synthesis in monocytes and endothelial cells. Biphasic effect of cyclosporin A.

E Carlsen1, G Gaudernack, C Filion-Myklebust, K S Pettersen, H Prydz.   

Abstract

Monocytes and endothelial cells were stimulated in co-culture with allogeneic lymphocytes to produce thromboplastin (TPL). The induction was biphasic, an early response (8-24 h) was greatly augmented by cyclosporin A (CS) (0.5-5 micrograms/ml) whereas the late response (day 3-4) was inhibited. Prednisolone inhibited both responses. Both drugs inhibited lymphocyte proliferation. Interferon-gamma decreased MLC TPL activity but increased thymidine incorporation. CD4+ cells were instrumental in inducing the early TPL peak in monocytes, whereas CD8+ cells decreased the TPL effect. With endothelial cells both T cell classes were equally effective. Conditioned medium from MLC as well as from co-cultures of endothelial cells and lymphocytes induced early TPL synthesis in endothelial cells. Upon allogeneic stimulation monocytes, but not endothelial cells, produced a significant amount of F-VII, most of which was apparently undercarboxylated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526700      PMCID: PMC1541888     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  The endotoxin-induced coagulant activity of human monocytes.

Authors:  R P Rivers; W E Hathaway; W L Weston
Journal:  Br J Haematol       Date:  1975-07       Impact factor: 6.998

2.  Procoagulant activity in renal transplant recipients.

Authors:  P F Halloran; M A Aprile; G J Haddad; M A Robinette
Journal:  Transplantation       Date:  1985-04       Impact factor: 4.939

3.  The significance of monocytes in glomeruli of human renal transplants.

Authors:  T R Harry; G A Coles; M Davies; D Bryant; G T Williams; P J Griffin
Journal:  Transplantation       Date:  1984-01       Impact factor: 4.939

4.  Cellular cooperation in endothelial cell thromboplastin synthesis.

Authors:  T Lyberg; K S Galdal; S A Evensen; H Prydz
Journal:  Br J Haematol       Date:  1983-01       Impact factor: 6.998

5.  Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.

Authors:  A D Hess; P J Tutschka
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  Enhancement of monocyte thromboplastin activity by antigenically stimulated lymphocytes: a link between immune reactivity and blood coagulation.

Authors:  C J van Ginkel; W P Zeijlemaker; L A Stricker; J I Oh; W G van Aken
Journal:  Eur J Immunol       Date:  1981-07       Impact factor: 5.532

7.  Effect of some drugs on thromboplastin (factor III) activity of human monocytes in vitro.

Authors:  H Prydz; T Lyberg
Journal:  Biochem Pharmacol       Date:  1980-01-01       Impact factor: 5.858

8.  Intravascular coagulation (IVC) in human renal allograft rejection.

Authors:  G J Busch; W E Braun; C B Carpenter; J M Corson; E R Galvanek; E S Reynolds; J P Merrill; G J Dammin
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

9.  Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction.

Authors:  K Atkinson; J C Biggs; K Britton; R Short; R Mrongovius; A Concannon; A Dodds
Journal:  Br J Haematol       Date:  1984-02       Impact factor: 6.998

10.  Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR.

Authors:  H Helin; T S Edgington
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  1 in total

1.  Flow cytometric analysis of tissue factor (TF) expression on stimulated monocytes--comparison to procoagulant activity of mononuclear blood cells.

Authors:  T Luther; C Flössel; V Hietschhold; R Koslowski; M Müller
Journal:  Blut       Date:  1990-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.